Home > Insider Trading > Filing (0000899243-20-012172)

Filing Details

Accession Number:: 0000899243-20-012172
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-05-06 19:32:19
Reporting Period:: 2020-05-05

Accepted Time:: 2020-05-06 19:32:19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1327273	Lyra Therapeutics Inc.	LYRA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1218581	T Edward Anderson	C/O Lyra Therapeutics, Inc. 480 Arsenal Way Watertown MA 02472		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-05-05	651,453	$0.00	651,453	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2020-05-05	319,303	$0.00	319,303	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2020-05-05	471,929	$0.00	471,929	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2020-05-05	21,060	$8.63	672,513	No	4	X	Indirect	See footnote
Common Stock	Disposition	2020-05-05	11,360	$16.00	661,153	No	4	S	Indirect	See footnote
Common Stock	Acquisiton	2020-05-05	10,322	$8.63	329,625	No	4	X	Indirect	See footnote
Common Stock	Disposition	2020-05-05	5,568	$16.00	324,057	No	4	S	Indirect	See footnote
Common Stock	Acquisiton	2020-05-05	13,449	$8.63	485,378	No	4	X	Indirect	See footnote
Common Stock	Disposition	2020-05-05	7,255	$16.00	478,123	No	4	S	Indirect	See footnote
Common Stock	Acquisiton	2020-05-05	117,439	$16.00	778,592	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2020-05-05	57,561	$16.00	381,618	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2020-05-05	75,000	$16.00	553,123	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	X	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	X	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	X	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A-1/A Convertible Preferred Stock	Disposition	2020-05-05	1,157,670	$0.00	33,572	$0.00
Common Stock	Series A-1/A Convertible Preferred Stock	Disposition	2020-05-05	567,420	$0.00	16,455	$0.00
Common Stock	Series A-1/A Convertible Preferred Stock	Disposition	2020-05-05	1,725,090	$0.00	50,027	$0.00
Common Stock	Series A-1/B Convertible Preferred Stock	Disposition	2020-05-05	1,105,754	$0.00	32,066	$0.00
Common Stock	Series A-1/B Convertible Preferred Stock	Disposition	2020-05-05	541,973	$0.00	15,717	$0.00
Common Stock	Series A-1/B Convertible Preferred Stock	Disposition	2020-05-05	1,647,727	$0.00	47,783	$0.00
Common Stock	Series A-1/C Convertible Preferred Stock	Disposition	2020-05-05	3,051,758	$0.00	88,500	$0.00
Common Stock	Series A-1/C Convertible Preferred Stock	Disposition	2020-05-05	1,495,786	$0.00	43,377	$0.00
Common Stock	Series A-1/C Convertible Preferred Stock	Disposition	2020-05-05	1,948,948	$0.00	56,519	$0.00
Common Stock	Series A-2 Convertible Preferred Stock	Disposition	2020-05-05	3,270,702	$0.00	94,849	$0.00
Common Stock	Series A-2 Convertible Preferred Stock	Disposition	2020-05-05	1,603,102	$0.00	46,489	$0.00
Common Stock	Series A-2 Convertible Preferred Stock	Disposition	2020-05-05	2,088,772	$0.00	60,573	$0.00
Common Stock	Series A-3 Convertible Preferred Stock	Disposition	2020-05-05	4,587,608	$0.00	133,039	$0.00
Common Stock	Series A-3 Convertible Preferred Stock	Disposition	2020-05-05	2,248,569	$0.00	65,208	$0.00
Common Stock	Series A-3 Convertible Preferred Stock	Disposition	2020-05-05	2,929,790	$0.00	84,963	$0.00
Common Stock	Series A-4 Convertible Preferred Stock	Disposition	2020-05-05	3,745,346	$0.00	108,614	$0.00
Common Stock	Series A-4 Convertible Preferred Stock	Disposition	2020-05-05	1,835,743	$0.00	53,236	$0.00
Common Stock	Series A-4 Convertible Preferred Stock	Disposition	2020-05-05	2,391,895	$0.00	69,364	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2020-05-05	3,124,633	$0.00	90,613	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2020-05-05	1,531,507	$0.00	44,413	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2020-05-05	1,995,489	$0.00	57,868	$0.00
Common Stock	Series C Convertible Preferred Stock	Disposition	2020-05-05	2,420,729	$0.00	70,200	$0.00
Common Stock	Series C Convertible Preferred Stock	Disposition	2020-05-05	1,186,496	$0.00	34,408	$0.00
Common Stock	Series C Convertible Preferred Stock	Disposition	2020-05-05	1,545,953	$0.00	44,832	$0.00
Common Stock	Common Warrants	Disposition	2020-05-05	21,060	$0.00	21,060	$8.63
Common Stock	Common Warrants	Disposition	2020-05-05	10,322	$0.00	10,322	$8.63
Common Stock	Common Warrants	Disposition	2020-05-05	13,449	$0.00	13,449	$8.63

Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
		No	4	C	Indirect
		No	4	C	Indirect
		No	4	C	Indirect
		No	4	C	Indirect
		No	4	C	Indirect
		No	4	C	Indirect
		No	4	C	Indirect
		No	4	C	Indirect
		No	4	C	Indirect
		No	4	C	Indirect
		No	4	C	Indirect
		No	4	C	Indirect
		No	4	C	Indirect
		No	4	C	Indirect
		No	4	C	Indirect
		No	4	C	Indirect
		No	4	C	Indirect
		No	4	C	Indirect
		No	4	C	Indirect
		No	4	C	Indirect
		No	4	C	Indirect
		No	4	C	Indirect
		No	4	C	Indirect
		No	4	C	Indirect
2020-01-17	2030-01-10	No	4	X	Indirect
2020-01-17	2030-01-10	No	4	X	Indirect
2020-01-17	2030-01-10	No	4	X	Indirect

Footnotes

Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date.
The reportable securities are owned directly by North Bridge Venture Partners V-A, L.P. ("NBVP V-A"). North Bridge Venture Management V, L.P. ("NBVM V") is the sole general partner of NBVP V-A and North Bridge Venture Management GP, LLC ("NBVM GP") is the sole general partner of NBVM V. Each of the Reporting Person, a member of the Issuer's board of directors, and Richard A. D'Amore ("D'Amore") are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-A. Each of NBVM V, NBVM GP, the Reporting Person and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
The reportable securities are owned directly by North Bridge Venture Partners V-B, L.P. ("NBVP V-B"). NBVM V is the sole general partner of NBVP V-B and NBVM GP is the sole general partner of NBVM V. Each of the Reporting Person, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-B. Each of NBVM V, NBVM GP, the Reporting Person and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. ("NBVP VI"). North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI and NBVM GP is the sole general partner of NBVM VI. Each of the Reporting Person, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP, the Reporting Person and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
On May 5, 2020, NBVP V-A exercised a warrant to purchase 21,060 shares of the Issuer's common stock for $16.00 a share, which represents the Issuer's initial public offering price. In connection with the automatic net exercise of the warrant immediately prior to the closing of the Issuer's initial public offering, the Issuer withheld 11,360 of the warrant shares to pay the exercise price and issued the remaining warrant shares to NBVP V-A. The Issuer also paid $12.20 to NBVP V-A in lieu of a fractional share.
On May 5, 2020, NBVP V-B exercised a warrant to purchsae 10,322 shares of the Issuer's common stock for $16.00 a share, which represents the Issuer's initial public offering price. In connection with the automatic net exercise of the warrant immediately prior to the closing of the Issuer's initial public offering, the Issuer withheld 5,568 of the warrant shares to pay the exercise price and issued the remaining warrant shares to NBVP V-B. The Issuer also paid $9.14 to NBVP V-B in lieu of a fractional share.
On May 5, 2020, NBVP VI exercised a warrant to purchase 13,449 shares of the Issuer's common stock for $16.00 a share, which represents the Issuer's initial public offering price. In connection with the automatic net exercise of the warrant immediately prior to the closing of the Issuer's initial public offering, the Issuer withheld 7,255 of the warrant shares to pay the exercise price and issued the remaining warrant shares to NBVP VI. The Issuer also paid $15.13 to NBVP VI in lieu of a fractional share.